Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Beauty Health Company (SKIN) USD0.0001 A

Sell:$17.49 Buy:$17.53 Change: $0.13 (0.75%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.13 (0.75%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.13 (0.75%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

The Beauty Health Company, formerly Vesper Healthcare Acquisition Corp., is a category-creating beauty health company focused on bringing beauty products to market. The Company's flagship brand, HydraFacial, is a beauty health platform and ecosystem with a community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions. HydraFacial uses delivery system to cleanse, extract, and hydrate skin, using patented hydra dermabrasion technology and serums that are made with nourishing ingredients. HydraFacial and Perk products are available in over 87 countries with approximately 17,000 delivery systems globally. The Company operates in Germany, Australia, France and Mexico.

Contact details

2165 Spring Street
United States
+1 (908) 3044504

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$2.27 billion
Shares in issue:
144.92 million
Personal Products
United States
US dollar

Key personnel

  • Brenton Saunders
    Executive Chairman
  • Clinton Carnell
    Chief Executive Officer, Director
  • Liyuan Woo
    Chief Financial Officer
  • Daniel Watson
    Executive Vice President, Americas Sales

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.